Anti-PI 3 Kinase p85 alpha 抗体 [EPR18702]
Anti-PI 3 Kinase p85 alpha antibody [EPR18702]
- 20ul selling size
- RabMAb
- Recombinant
- KO Validated
- 詳細を見る
5
(2 Reviews)
|
(388 Publications)
Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (ab191606) is a rabbit monoclonal antibody detecting PI 3 Kinase p85 alpha in Western Blot, Flow Cytometry (Intra), Flow Cytometry, IP, ICC/IF. Suitable for African green monkey, Human, Mouse, Rat.
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 220 publications
別名を表示する
GRB1, PIK3R1, Phosphatidylinositol 3-kinase regulatory subunit alpha, PI3-kinase regulatory subunit alpha, PI3K regulatory subunit alpha, PtdIns-3-kinase regulatory subunit alpha, Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha, PI3-kinase subunit p85-alpha, PtdIns-3-kinase regulatory subunit p85-alpha
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (AB191606)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HepG2 (Human liver hepatocellular carcinoma cell line) cells labeling PI3K p85 with ab191606 at 1/250 dilution, followed by Goat Anti-Rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing cytoplasmic staining on HepG2 cell line. The nuclear counter stain is DAPI (blue). Tubulin is detected with Anti-alpha Tubulin antibody - Loading Control (ab7291) at 1/1000 dilution and Goat Anti-Mouse IgG (AlexaFluor®594) preadsorbed (ab150120) at 1/1000 dilution (red).
The negative controls are as follows :
-ve control 1 : ab191606 at 1/500 dilution followed by ab150120 at 1/1000 dilution.
-ve control 2 : ab7291 at 1/1000 dilution followed by ab150077 at 1/1000 dilution.
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (AB191606)
Overlay histogram showing HepG2 cells fixed in 4% PFA and stained with ab191606 at a dilution of 1/80 (red line). The secondary antibody used was Alexa Fluor® 488 goat anti-rabbit at a dilution of 1/500. Rabbit monoclonal IgG (ab172730)was used as an isotype control (black line) and cells incubated in the absence of both primary and secondary antibody were used as a negative control (blue line).
- IP
Supplier Data
Immunoprecipitation - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (AB191606)
PI3K p85 was immunoprecipitated from 1mg of MCF7 (Human breast adenocarcinoma cell line) whole cell lysate with ab191606 at 1/50 dilution. Western blot was performed from the immunoprecipitate using ab191606 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10000 dilution.
Lane 1 : MCF7 whole cell lysate, 10μg (Input).
Lane 2 : ab191606 IP in MCF7 whole cell lysate.
Lane 3 : Rabbit IgG, monoclonal - Isotype Control (ab172730) instead of ab191606 in MCF7 whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 5 seconds.
All lanes:
Immunoprecipitation - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (ab191606)
Predicted band size: 83 kDa
false
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (AB191606)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 100% Methanol permeabilized NIH/3T3 (Mouse embryonic fibroblast cell line) cells labeling PI3K p85 with ab191606 at 1/250 dilution, followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing cytoplasmic staining on NIH/3T3 cell line. The nuclear counter stain is DAPI (blue). Tubulin is detected with Anti-alpha Tubulin antibody - Loading Control (ab7291) at 1/1000 dilution and Goat Anti-Mouse IgG (AlexaFluor®594) preadsorbed (ab150120) at 1/1000 dilution (red).
The negative controls are as follows :
-ve control 1 : ab191606 at 1/500 dilution followed by ab150120 at 1/1000 dilution.
-ve control 2 : ab7291 at 1/1000 dilution followed by ab150077 at 1/1000 dilution.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (AB191606)
Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed NIH/3T3 (Mouse embryonic fibroblast cell line) cells labeling PI3K p85 with ab191606 at 1/150 dilution (red) compared with a Rabbit IgG,monoclonal -Isotype control (ab172730) (black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (blue). Goat anti Rabbit IgG (Alexa Fluorr® 488) at 1/500 dilution was used as the secondary antibody.
- WB
Lab
Western blot - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (AB191606)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Lysates were freshly made and used for Western blotting immediately to minimize protein degradation.
Compared with ab40755, ab191606 has higher sensitivity. We recommend ab124805 as an alternative for testing western blot.
We suggest optimizing experimental protocols (increasing lysate amount, using lower dilution or higher sensitivity ECL substrate) to improve results when using ab197896 in western blot.
Lane 1:
Western blot - Anti-PI 3 Kinase p85 alpha antibody [EP380Y] (<a href='/products/primary-antibodies/pi-3-kinase-p85-alpha-antibody-ep380y-ab40755'>ab40755</a>) at 1/1000 dilution
Lane 2:
Western blot - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (ab191606) at 1/1000 dilution
All lanes:
Jurkat (human T cell leukemia T lymphocyte) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 85 kDa
false
Exposure time: 40s
- WB
Supplier Data
Western blot - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (AB191606)
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure time : Lane 1 and 2 : 10 seconds; Lane 3 and 4 : 3 seconds.
The molecular weight observed is consistent with what have been described in the literatures (PMID : 8921377, 12649157).
All lanes:
Western blot - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (ab191606) at 1/1000 dilution
Lane 1:
HepG2 (Human liver hepatocellular carcinoma cell line) whole cell lysate at 20 µg
Lane 2:
MCF7 (Human breast adenocarcinoma cell line) whole cell lysate at 20 µg
Lane 3:
Jurkat (Human T cell leukemia cell line from peripheral blood) whole cell lysate at 20 µg
Lane 4:
Raji (Human Burkitt's lymphoma cell line) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 83 kDa
Observed band size: 46 kDa,85 kDa
false
- WB
Unknown
Western blot - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (AB191606)
Lane 1 : Wild type HAP1 whole cell lysate (20 μg)
Lane 2 : PIK3R1 knockout HAP1 whole cell lysate (20 μg)
Lane 3 : Jurkat whole cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab191606 observed at 90 kDa. Red - loading control, ab9484, observed at 37 kDa.
ab191606 was shown to specifically react with PIK3R1 when PIK3R1 knockout samples were used. Wild-type and PIK3R1 knockout samples were subjected to SDS-PAGE. ab191606 and ab9484 (Mouse anti GAPDH loading control) were incubated overnight at 4°C at 1000 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (ab191606)
Predicted band size: 83 kDa
false
- WB
Lab
Western blot - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (AB191606)
Lanes 1- 2 : Merged signal (red and green). Green - ab191606 observed at 90 kDa. Red - Anti-GAPDH antibody [6C5] - Loading Control (ab8245) observed at 37 kDa.
ab191606 was shown to react with PI 3 Kinase p85 alpha in wild-type HeLa cells in western blot. Loss of signal was observed when knockout cell line ab265116 (knockout cell lysate ab257029) was used. Wild-type HeLa and PIK3R1 knockout HeLa cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab191606 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (ab191606) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
PIK3R1 knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human PIK3R1 (PI 3 Kinase p85 alpha) knockout HeLa cell line (<a href='/products/cell-lines/human-pik3r1-pi-3-kinase-p85-alpha-knockout-hela-cell-line-ab265116'>ab265116</a>)
Predicted band size: 83 kDa
Observed band size: 90 kDa
false
- WB
Supplier Data
Western blot - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (AB191606)
Blocking/Dilution buffer : 5% NFDM/TBST.
The molecular weight observed is consistent with what have been described in the literatures (PMID : 8921377, 12649157).
All lanes:
Western blot - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (ab191606) at 1/1000 dilution
Lane 1:
Human fetal liver lysate at 10 µg
Lane 2:
Human fetal heart lysate at 10 µg
Lane 3:
Human fetal kidney lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG Peroxidase Conjugate, specific to the non-reduced form of IgG at 1/10000 dilution
Predicted band size: 83 kDa
Observed band size: 46 kDa,85 kDa
false
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (AB191606)
Blocking/Dilution buffer : 5% NFDM/TBST.
Human PI3K p85 alpha full length recombinant protein contain aa1-724 with a His-Tag® (Cat#ab84769). Human PI3K p85 beta full length recombinant protein contain aa1-728 with a His-Tag® (Cat#ab125568).
All lanes:
Western blot - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (ab191606) at 1/20000 dilution
Lane 1:
Human PI3K p85 alpha full length recombinant protein at 0.01 µg
Lane 2:
Human PI3K p85 beta full length recombinant protein at 0.01 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 41 kDa,83 kDa
Observed band size: 55-60 kDa
false
Exposure time: 5s
- WB
Supplier Data
Western blot - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (AB191606)
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure time : Lane 1-8 : 3 minutes; Lane 9-12 : 10 seconds.
The molecular weight observed is consistent with what have been described in the literatures (PMID : 8921377, 12649157).
All lanes:
Western blot - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (ab191606) at 1/1000 dilution
Lane 1:
Mouse brain lysate at 10 µg
Lane 2:
Mouse heart lysate at 10 µg
Lane 3:
Mouse kidney lysate at 10 µg
Lane 4:
Mouse spleen lysate at 10 µg
Lane 5:
Rat brain lysate at 10 µg
Lane 6:
Rat heart lysate at 10 µg
Lane 7:
Rat kidney lysate at 10 µg
Lane 8:
Rat spleen lysate at 10 µg
Lane 9:
C6 (Rat glial tumor cell line) whole cell lysate at 10 µg
Lane 10:
RAW 264.7 (Mouse macrophage cell line transformed with Abelson murine leukemia virus) whole cell lysate at 10 µg
Lane 11:
PC-12 (Rat adrenal gland pheochromocytoma cell line) whole cell lysate at 10 µg
Lane 12:
NIH/3T3 (Mouse embryonic fibroblast cell line) whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 83 kDa
Observed band size: 46 kDa,85 kDa
false
関連する標識済み抗体及び組成の異なる製品 (4)
-
578 PE
PE Anti-PI 3 Kinase p85 alpha antibody [EPR18702]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-PI 3 Kinase p85 alpha antibody [EPR18702]
-
660 APC
APC Anti-PI 3 Kinase p85 alpha antibody [EPR18702]
-
Anti-PI 3 Kinase p85 alpha antibody [EPR18702] - BSA and Azide free
Reactivity data
製品の詳細
What is this antibody validated in?
Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (ab191606) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunoprecipitation (IP), Immunocytochemistry/immunofluorescence (ICC/IF) in African green monkey, Human, Mouse, Rat samples.
What is the molecular weight of PI 3 Kinase p85 alpha?
Anti-PI 3 Kinase p85 alpha [EPR18702] (ab191606) specifically detects a band for PI 3 Kinase p85 alpha (UniProt: Q63787) at a molecular weight of 84kDa.
Trusted by the scientific community
Anti-PI 3 Kinase p85 alpha [EPR18702] (ab191606) was first used in a scientific publication in 2016 and has been cited over 220 times in peer-reviewed journals.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.
Specificity confirmed
The specificity of Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (ab191606) has been confirmed by Western blot testing in PIK3R1 Knockout HAP1 cells.
Other related products
We have a range of other formats of antibody clone [EPR18702] also available for your convenience: ab191606, Carrier free - ab223792, APC - ab225369, PE - ab225370, Alexa Fluor® 488 - ab225371
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
P85 alpha modulates intracellular signaling by interacting with other proteins in a complex formation with catalytic subunit p110. This interaction enables the initiation of downstream signaling cascades controlling cell growth proliferation and survival. PI 3 kinase activity mediated by p85 alpha is integral to cellular homeostasis and metabolism helping to execute cellular responses to a variety of growth factors and hormones.
Pathways
PI 3 Kinase p85 alpha integrates into two principal signaling networks: the PI3K-Akt and mTOR pathways. These pathways are instrumental for regulating anabolic processes and cell survival. The p85 form of PI3K interacts with additional proteins such as Akt and mTOR coordinating cellular energy balance promoting protein synthesis and inhibiting apoptosis. Through these interactions the protein ensures that cells respond accurately to nutritional and stress signals.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (388)
Recent publications for all applications. Explore the full list and refine your search
PloS one 20:e0332202 PubMed40991530
2025
Applications
Unspecified application
Species
Unspecified reactive species
Science advances 11:eadu5571 PubMed40961206
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of diabetes research 2025:9601959 PubMed40933728
2025
Applications
Unspecified application
Species
Unspecified reactive species
Open medicine (Warsaw, Poland) 20:20251261 PubMed40918151
2025
Applications
Unspecified application
Species
Unspecified reactive species
Acta pharmaceutica Sinica. B 15:4248-4264 PubMed40893673
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in medicine 12:1614592 PubMed40809438
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell biochemistry and function 43:e70108 PubMed40770889
2025
Applications
Unspecified application
Species
Unspecified reactive species
Pharmaceuticals (Basel, Switzerland) 18: PubMed40732297
2025
Applications
Unspecified application
Species
Unspecified reactive species
mSystems 10:e0014825 PubMed40693815
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:6389 PubMed40640139
2025
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com